Max Healthcare Institute Details Status of Litigation Against Kalinga Hospital Ltd. Before NCLT
Max Healthcare Institute Ltd has provided an update on ongoing litigation involving Kalinga Hospital Ltd. (KHL), a subsidiary of the company in which Max Healthcare holds a majority equity stake, acquired from another shareholder.The dispute involves an interlocutory petition filed before the National Company Law Tribunal (NCLT). This petition was initiated by BRS Capital Two Pte. Limited and requests a stay on a Postal Ballot Notice issued by KHL. The notice, dated May 29, 2026, relates to increasing borrowing limits and creating a charge on assets of the company.
The proceedings regarding this matter were heard before the NCLT on July 7, 2026. Both parties submitted their respective submissions during the hearing.
Following the discussion, the National Company Law Tribunal adjourned the matters for further hearing until July 23, 2026.
Key details concerning the legal proceedings are summarized below:
| Particulars | Details |
|---|---|
| Status Update | The NCLT heard submissions from all parties regarding the interlocutory petition and adjourned the matter to July 23, 2026, for further hearing. |
| Litigation involving Key Management Personnel | Not applicable. |
| Settlement Details | Not applicable. |
MAXHEALTH Stock Price Movement
Shares of Max Healthcare Institute Limited are edging higher to ₹1119.7 as of 10:50 AM today, rising by 0.12% in live trading. The equity sees robust intraday interest, with a volume of 294,959 shares traded so far in the market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.